Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors

R. Knerich, G. Robustelli della Cuna, G. Butti, L. Pavesi, D. Adinolfi, P. Preti, D. Locatelli

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.

Original languageEnglish
Pages (from-to)19-24
Number of pages6
JournalJournal of Neurosurgical Sciences
Volume29
Issue number1
Publication statusPublished - 1985

Fingerprint

Brain Neoplasms
Immunotherapy
Lomustine
Drug Therapy
Carmustine
Levamisole
Mycobacterium bovis
Radiotherapy
Clinical Trials
Survival
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Knerich, R., Robustelli della Cuna, G., Butti, G., Pavesi, L., Adinolfi, D., Preti, P., & Locatelli, D. (1985). Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors. Journal of Neurosurgical Sciences, 29(1), 19-24.

Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors. / Knerich, R.; Robustelli della Cuna, G.; Butti, G.; Pavesi, L.; Adinolfi, D.; Preti, P.; Locatelli, D.

In: Journal of Neurosurgical Sciences, Vol. 29, No. 1, 1985, p. 19-24.

Research output: Contribution to journalArticle

Knerich, R, Robustelli della Cuna, G, Butti, G, Pavesi, L, Adinolfi, D, Preti, P & Locatelli, D 1985, 'Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors', Journal of Neurosurgical Sciences, vol. 29, no. 1, pp. 19-24.
Knerich R, Robustelli della Cuna G, Butti G, Pavesi L, Adinolfi D, Preti P et al. Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors. Journal of Neurosurgical Sciences. 1985;29(1):19-24.
Knerich, R. ; Robustelli della Cuna, G. ; Butti, G. ; Pavesi, L. ; Adinolfi, D. ; Preti, P. ; Locatelli, D. / Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors. In: Journal of Neurosurgical Sciences. 1985 ; Vol. 29, No. 1. pp. 19-24.
@article{357bc80cf10f4f24b42ec6a0e8db9aa6,
title = "Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors",
abstract = "The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.",
author = "R. Knerich and {Robustelli della Cuna}, G. and G. Butti and L. Pavesi and D. Adinolfi and P. Preti and D. Locatelli",
year = "1985",
language = "English",
volume = "29",
pages = "19--24",
journal = "Journal of Neurosurgical Sciences",
issn = "0026-4881",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors

AU - Knerich, R.

AU - Robustelli della Cuna, G.

AU - Butti, G.

AU - Pavesi, L.

AU - Adinolfi, D.

AU - Preti, P.

AU - Locatelli, D.

PY - 1985

Y1 - 1985

N2 - The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.

AB - The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.

UR - http://www.scopus.com/inward/record.url?scp=0022391133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022391133&partnerID=8YFLogxK

M3 - Article

C2 - 3906050

AN - SCOPUS:0022391133

VL - 29

SP - 19

EP - 24

JO - Journal of Neurosurgical Sciences

JF - Journal of Neurosurgical Sciences

SN - 0026-4881

IS - 1

ER -